Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force

Open access
Brody, S · 2003 · Obstetrics & Gynecology

Abstract

OBJECTIVE: To systematically review the evidence for screening for gestational diabetes mellitus (GDM). DATA SOURCES: We established eligibility criteria for relevant studies. We systematically searched MEDLINE and the Cochrane Collaboration Library for studies meeting eligibility criteria. We supplemented this search with further studies identified from reference lists of reviews. METHODS OF STUDY SELECTION: Two reviewers examined each article for eligibility. A single reviewer abstracted relevant data from the included articles; a second reviewer checked the abstractions. We graded the quality of the articles according to criteria developed by the U.S. Preventive Services Task Force. TABULATION, INTEGRATION, AND RESULTS: No well-conducted, randomized, controlled trial provides direct evidence for the health benefits of screening for GDM. The evidence is unclear regarding the optimal screening and reference diagnostic test for GDM. The impact of hyperglycemia on adverse maternal and neonatal health outcomes is probably continuous. Although insulin therapy decreases the incidence of fetal macrosomia for those women with more severe degrees of hyperglycemia, the magnitude of any effect on maternal and neonatal health outcomes is not clear. The evidence is insufficient to determine the magnitude of health benefit for any treatment among the large number of women with GDM at milder degrees of hyperglycemia. We found limited evidence regarding the potential adverse effects of screening for GDM. CONCLUSION: Because of the lack of high-quality evidence concerning critical issues, we are unable to determine the extent to which screening has an important impact on maternal and neonatal health outcomes. A randomized, controlled trial of screening is necessary to answer the many remaining questions.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0029-7844(02)03057-0

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 98 references

Cited by

See all 200

Metadata

Authors
Brody, S.
Affiliations
University of North Carolina at Chapel Hill (US)
Corresponding author
Brody, S
Venue
Obstetrics & Gynecology
Published
2003-02
Volume
101
Issue
2
Pages
380-392
ISSN
0029-7844 (ISSN-L)
OpenAlex
W2023952844
Cited by
200
References
98
Citations by year
2023: 1 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 7 · 2015: 10 · 2014: 10 · 2013: 8 · 2012: 10
FWCI
18.52
Type
journal article
Language
en
Open access
Locations
  • Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and Neonatal Healthcare
Keywords
gestational diabetes mellitus, screening, hyperglycemia in pregnancy, macrosomia, insulin therapy, maternal outcomes, neonatal outcomes, diagnostic testing, USPSTF recommendations
MeSH terms
Adolescent, Adult, Female, Glucose Tolerance Test, Humans, Male, Mass Screening, Maternal Mortality, Middle Aged, Pregnancy, Pregnancy Outcome, Prenatal Care, Primary Prevention, Risk Factors, United States, Prevalence, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. https://app.cochat.ai/papers/10.1016/s0029-7844(02)03057-0
The paper
Brody, S. (2003). Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstetrics & Gynecology. https://doi.org/10.1016/s0029-7844(02)03057-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.